建滔集團(00148.HK)擬回購不超5億港元股份
格隆匯9月25日丨建滔集團(00148.HK)宣佈,決定根據公司股東於2019年5月27日舉行的股東周年大會上授予董事會的一般授權行使其權力,並自今天起開始在聯交所購回公司股份。公司預計進行建議股份購回可持續數月,惟視乎市場及其他狀況而定。
儘管根據股份購回授權,公司獲授權最多於聯交所購回1.08億股股份,相當於股東周年大會日期已發行股份總數之10%,但公司現時預計建議股份購回涉及的金額不會超過5億港元。
公司認為,公司股份的價值一直被低估,現時成交價並不反映其內在價值。經考慮本公司的營運及財務狀況,本公司相信其現有的財務資源足以進行建議股份購回,同時維持其穩健的財務狀況以繼續本公司的正常營運。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.